Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_assertion type Assertion NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_head.
- NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_assertion description "[Study shows that loss or reduced expression of DAPK1 underlies cases of heritable predisposition to chronic lymphocytic leukemia (CLL) and epigenetic silencing of DAPK1 by promoter methylation occurs in almost all sporadic CLL cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_provenance.
- NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_assertion evidence source_evidence_literature NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_provenance.
- NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_assertion SIO_000772 17540169 NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_provenance.
- NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_assertion wasDerivedFrom lhgdn-20090331 NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_provenance.
- NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_assertion wasGeneratedBy ECO_0000203 NP196830.RAfkgEYGYfe-WfVTAUv0uY9zegifx7VRv-Ormb_LrQUZg130_provenance.